BSW Wealth Partners Purchases Shares of 2,641 Aflac Incorporated (NYSE:AFL)

BSW Wealth Partners bought a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 2,641 shares of the financial services provider's stock, valued at approximately $294,000.

Other institutional investors also recently modified their holdings of the company. Private Trust Co. NA increased its holdings in shares of Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider's stock worth $791,000 after buying an additional 99 shares in the last quarter. Phillips Wealth Planners LLC lifted its position in shares of Aflac by 1.5% during the 1st quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider's stock worth $711,000 after buying an additional 100 shares in the last quarter. Optas LLC boosted its stake in Aflac by 3.5% in the first quarter. Optas LLC now owns 2,949 shares of the financial services provider's stock valued at $328,000 after acquiring an additional 101 shares during the last quarter. Family Legacy Inc. lifted its holdings in Aflac by 4.3% during the fourth quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock valued at $270,000 after purchasing an additional 107 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC boosted its stake in Aflac by 1.9% in the 4th quarter. Ashton Thomas Private Wealth LLC now owns 5,927 shares of the financial services provider's stock worth $613,000 after purchasing an additional 110 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Raymond James Financial decreased their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a report on Thursday, May 29th. UBS Group boosted their price target on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Wells Fargo & Company raised their target price on shares of Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 6th. Barclays raised their target price on shares of Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research note on Thursday, May 1st. Finally, Piper Sandler upped their target price on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $106.50.

Insider Buying and Selling

In other news, Director Masatoshi Koide sold 37,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the sale, the director directly owned 70,992 shares in the company, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the sale, the director owned 26,096 shares in the company, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 40,750 shares of company stock valued at $4,304,295. 0.80% of the stock is owned by company insiders.

Aflac Stock Down 2.1%

Shares of AFL stock traded down $2.27 during mid-day trading on Wednesday, reaching $103.51. 1,524,184 shares of the company were exchanged, compared to its average volume of 2,150,653. The company has a market capitalization of $55.96 billion, a P/E ratio of 16.17, a P/E/G ratio of 3.26 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. Aflac Incorporated has a fifty-two week low of $88.00 and a fifty-two week high of $115.50. The business's 50 day simple moving average is $104.51 and its 200 day simple moving average is $105.22.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The business had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same period in the previous year, the company posted $1.66 earnings per share. Aflac's revenue was down 37.5% compared to the same quarter last year. Research analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were issued a $0.58 dividend. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 annualized dividend and a yield of 2.24%. Aflac's dividend payout ratio (DPR) is presently 36.25%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.